R&D Changing Faces: Pharma and biotech hires, September 2026 There was plenty of movement at the top of pharma and biotech in September, with leadership changes spanning some of the industry’s biggest names.
R&D Changing Faces: Board of Director and Advisory Board hires, ... Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August.
Digital Changing Faces: Digital and supplier hires, August 2026 Digital health, clinical technology, contract services, and life sciences suppliers all saw notable leadership changes last month.
R&D Changing Faces: Pharma and biotech hires, August 2026 August brought another wave of leadership changes across biotech, pharma, and research organisations.
R&D Changing Faces: Board appointments, June and July 2026 Board appointments June/July brought together veterans from across the pharmaceutical industry, venture capital, healthcare technology, and academia
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires, Jun... Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.